Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Sekito

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Diabetes|April 17, 2026
Activating Transcription Factor 6α Governs Stress-Adaptive Pancreatic β-Cell Mass Expansion by Coordinating Proliferation and SurvivalDaisuke Otani, Takaaki Murakami, Muhammad Fauzi, et al.
Nature Communications|January 23, 2026
Endothelial stem cells of the retinal vasculature reside in the optic nerveSusumu Sakimoto, Toru Takigawa, Akiko Oguchi, et al.
Cancer Science|October 8, 2025
Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle-Invasive Bladder CancerYusuke Sugino, Xin Bao, Sho Sekito, et al.
BJU International|February 12, 2024
Prognostic impact of histological discordance between transurethral resection and radical cystectomyAyumu Matsuda, Rikiya Taoka, Jun Miki, et al.
International Journal of Clinical Oncology|May 10, 2025
Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective studyTomokazu Sazuka, Rikiya Taoka, Jun Miki, et al.
International Journal of Clinical Oncology|July 21, 2025
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohortRyoichi Saito, Rikiya Taoka, Jun Miki, et al.
Cancer Medicine|April 30, 2025
Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated With Radical CystectomyShingo Hatakeyama, Rikiya Taoka, Jun Miki, et al.
Science (New York, N.Y.)|July 4, 2024
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseasesAkiko Oguchi, Akari Suzuki, Shuichiro Komatsu, et al.
Japanese Journal of Clinical Oncology|January 16, 2026
Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in JapanTaketo Kawai, Jun Miki, Rikiya Taoka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 5, 2025
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomyShuhei Hara, Wataru Fukuokaya, Jun Miki, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Diabetes|April 17, 2026
Activating Transcription Factor 6α Governs Stress-Adaptive Pancreatic β-Cell Mass Expansion by Coordinating Proliferation and SurvivalDaisuke Otani, Takaaki Murakami, Muhammad Fauzi, et al.
Nature Communications|January 23, 2026
Endothelial stem cells of the retinal vasculature reside in the optic nerveSusumu Sakimoto, Toru Takigawa, Akiko Oguchi, et al.
Cancer Science|October 8, 2025
Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle-Invasive Bladder CancerYusuke Sugino, Xin Bao, Sho Sekito, et al.
BJU International|February 12, 2024
Prognostic impact of histological discordance between transurethral resection and radical cystectomyAyumu Matsuda, Rikiya Taoka, Jun Miki, et al.
International Journal of Clinical Oncology|May 10, 2025
Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective studyTomokazu Sazuka, Rikiya Taoka, Jun Miki, et al.
International Journal of Clinical Oncology|July 21, 2025
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohortRyoichi Saito, Rikiya Taoka, Jun Miki, et al.
Cancer Medicine|April 30, 2025
Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated With Radical CystectomyShingo Hatakeyama, Rikiya Taoka, Jun Miki, et al.
Science (New York, N.Y.)|July 4, 2024
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseasesAkiko Oguchi, Akari Suzuki, Shuichiro Komatsu, et al.
Japanese Journal of Clinical Oncology|January 16, 2026
Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in JapanTaketo Kawai, Jun Miki, Rikiya Taoka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 5, 2025
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomyShuhei Hara, Wataru Fukuokaya, Jun Miki, et al.
Pageof 4